Page last updated: 2024-08-23

pipoxolan and Breast Cancer

pipoxolan has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahn, HK; Ahn, MS; Byun, JH; Jung, KH; Kang, MJ; Kim, HJ; Kim, JE; Kim, JH; Kim, MH; Koh, SJ; Lee, GW; Lee, KE; Lee, KS; Park, IH; Park, JH; Park, KH; Park, KU; Park, YH; Sim, SH; Sohn, J; Suh, KJ	1

Trials

1 trial(s) available for pipoxolan and Breast Cancer

Article	Year
Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B). Breast (Edinburgh, Scotland), 2022, Volume: 65 Topics: Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Dioxolanes; Female; Humans; Physicians; Receptor, ErbB-2; Trastuzumab	2022

Article

Year

Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B).

Breast (Edinburgh, Scotland), 2022, Volume: 65

Topics: Antineoplastic Combined Chemotherapy Protocols; Biosimilar Pharmaceuticals; Breast Neoplasms; Dioxolanes; Female; Humans; Physicians; Receptor, ErbB-2; Trastuzumab

2022